We also provided robust pre-clinical proof of concept data that transplantation of reparative macrophages, which were produced from BM-MNCs with M-CSF + IL-4 treatment, resulted in augmented therapeutic effects, compared to BM-MNC transplantation, in a murine model of MI. This evidence concerns the gene CSF1 and myocardial infarction.